Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Barbiturates in Refractory Status Epilepticus
NCT00265616Phase 3Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2006
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of propofol in status epilepticus (SE), sponsored by Brigham and Women's Hospital. Primary endpoint: Refractory Status Epilepticus Controlled With First Course of Study Drug at 5 days. Started May 2006; status: terminated.
02
Drugs
propofol
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT00265616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265616.